Affordable Access

deepdyve-link deepdyve-link
Publisher Website

HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53.

Authors
Type
Published Article
Journal
Cell Cycle
1551-4005
Publisher
Landes Bioscience
Publication Date
Volume
11
Issue
22
Pages
4181–4190
Identifiers
DOI: 10.4161/cc.22413
PMID: 23095642
Source
Medline
License
Unknown

Abstract

HER2/neu oncogene is frequently overexpressed in various types of cancer, and the (PI3K)-Akt signaling pathway is often activated in HER2-overexpressing cancer cells. CSN6, subunit 6 of the COP9 signalosome complex, is pivotal in regulating MDM2 to destabilize p53, but its upstream regulators remain unclear. Here we show that the HER2-Akt axis is linked to CSN6 regulation, and that Akt is a positive regulator of CSN6. Ectopic expression of Akt can increase the expression of CSN6; accordingly, Akt inhibition leads to CSN6 destabilization. Mechanistic studies show that Akt causes CSN6 phosphorylation at Ser 60, which, in turn, reduces ubiquitin-mediated protein degradation of CSN6. Significantly, Akt's positive impact on CSN6 elevation translates into p53 degradation, potentiating transformational activity and increasing DNA damage. Akt inhibition can attenuate these defects caused by CSN6. These data suggest that Akt is an important positive regulator of CSN6, and that activation of Akt in many types of cancer could lead to abnormal elevation of CSN6 and result in downregulated p53 and increased DNA damage, which promotes cancer cell growth.

Statistics

Seen <100 times